Form 4 for WVE Wave Life Sciences, Inc.
Accepted 2025-03-07 00:00:00 ET · period of report 2025-03-05 · accession 0000950170-25-035834 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-03-07 | 2025-03-05+ | WVE | Verdine Gregory L. | Dir | M - OptEx | $2.48 | +266.4K | 179.2K | New | +$660.7K |
| DM | 2025-03-07 | 2025-03-05+ | WVE | Verdine Gregory L. | Dir | M - OptEx | $0.00 | -266.4K | 133.4K | -67% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2025-03-07 | M | A | 133,402 | $2.48 | 312,517 | D | — | — | |
| 2 | Common | Ordinary Shares | 2025-03-05 | M | A | 133,000 | $2.48 | 179,155 | D | — | — | |
| 3 | Derivative | Share Option (right to buy) | 2025-03-07 | M | D | 133,402 | $0.00 | 0 | D | $2.48 · — to 2025-03-10 | 133,402 Ordinary Shares | (F1) The share options that were exercised via cash purchase in this reportable transaction were fully vested. |
| 4 | Derivative | Share Option (right to buy) | 2025-03-05 | M | D | 133,000 | $0.00 | 133,402 | D | $2.48 · — to 2025-03-10 | 133,000 Ordinary Shares | (F1) The share options that were exercised via cash purchase in this reportable transaction were fully vested. |